A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma

Journal of Molecular Diagnostics

Volumn 19, Issue 1, 2017, Pages 162-168

  Sorber, Laure ^a,b   Zwaenepoel, Karen ^a,b   Deschoolmeester, Vanessa ^a,b   Roeyen, Geert ^b   Lardon, Filip ^a   Rolfo, Christian ^a,b   Pauwels, Patrick ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; NUCLEIC ACID; UNCLASSIFIED DRUG; DIAGNOSTIC KIT; KRAS PROTEIN, HUMAN; PROTEIN P21; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; DNA ISOLATION; GENE MUTATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MOLECULAR DIAGNOSTICS; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PLASMA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; BLOOD; CARCINOMA, PANCREATIC DUCTAL; CASE CONTROL STUDY; COMPARATIVE STUDY; DIAGNOSTIC KIT; DNA MUTATIONAL ANALYSIS; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PANCREATIC NEOPLASMS;

BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS P21(RAS); REAGENT KITS, DIAGNOSTIC;

EID: 85006516024     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2016.09.009     Document Type: Article

References (22)

1. 1 Murtaza, M., Dawson, S.J., Tsui, D.W., Gale, D., Forshew, T., Piskorz, A.M., Parkinson, C., Chin, S.F., Kingsbury, Z., Wong, A.S., Marass, F., Humphray, S., Hadfield, J., Bentley, D., Chin, T.M., Brenton, J.D., Caldas, C., Rosenfeld, N., Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497 (2013), 108–112.
2. 2 Diaz, L.A. Jr., Williams, R.T., Wu, J., Kinde, I., Hecht, J.R., Berlin, J., Allen, B., Bozic, I., Reiter, J.G., Nowak, M.A., Kinzler, K.W., Oliner, K.S., Vogelstein, B., The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486 (2012), 537–540.
3. 3 Diaz, L.A. Jr., Bardelli, A., Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32 (2014), 579–586.
4. 4 Yong, E., Cancer biomarkers: written in blood. Nature 511 (2014), 524–526.
5. 5 Giacona, M.B., Ruben, G.C., Iczkowski, K.A., Roos, T.B., Porter, D.M., Sorenson, G.D., Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 17 (1998), 89–97.
6. 6 Jiang, P., Chan, C.W., Chan, K.C., Cheng, S.H., Wong, J., Wong, V.W., Wong, G.L., Chan, S.L., Mok, T.S., Chan, H.L., Lai, P.B., Chiu, R.W., Lo, Y.M., Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A 112 (2015), E1317–E1325.
7. 7 Devonshire, A.S., Whale, A.S., Gutteridge, A., Jones, G., Cowen, S., Foy, C.A., Huggett, J.F., Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. Anal Bioanal Chem 406 (2014), 6499–6512.
8. 8 Breitbach, S., Tug, S., Helmig, S., Zahn, D., Kubiak, T., Michal, M., Gori, T., Ehlert, T., Beiter, T., Simon, P., Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS One, 9, 2014, e87838.
9. 9 Zill, O.A., Greene, C., Sebisanovic, D., Siew, L., Leng, J., Vu, M., Hendifar, A.E., Wang, Z., Atreya, C.E., Kelley, R.K., Van Loon, K., Ko, A.H., Tempero, M.A., Bivona, T.G., Munster, P.N., Talasaz, A., Collisson, E., Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas. Cancer Discov 5 (2015), 1040–1048.
10. 10 Oxnard, G.R., Paweletz, C.P., Kuang, Y., Mach, S.L., O'Connell, A., Messineo, M.M., Luke, J.J., Butaney, M., Kirschmeier, P., Jackman, D.M., Janne, P.A., Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin Cancer Res 20 (2014), 1698–1705.
11. 11 Hyman, D.M., Diamond, E.L., Vibat, C.R., Hassaine, L., Poole, J.C., Patel, M., Holley, V.R., Cabrilo, G., Lu, T.T., Arcila, M.E., Chung, Y.R., Rampal, R., Lacouture, M.E., Rosen, N., Meric-Bernstam, F., Baselga, J., Kurzrock, R., Erlander, M.G., Janku, F., Abdel-Wahab, O., Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders. Cancer Discov 5 (2015), 64–71.
12. 12 Sefrioui, D., Sarafan-Vasseur, N., Beaussire, L., Baretti, M., Gangloff, A., Blanchard, F., Clatot, F., Sabourin, J.C., Sesboue, R., Frebourg, T., Michel, P., Di Fiore, F., Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer. Dig Liver Dis 47 (2015), 884–890.
13. 13 Page, K., Guttery, D.S., Zahra, N., Primrose, L., Elshaw, S.R., Pringle, J.H., Blighe, K., Marchese, S.D., Hills, A., Woodley, L., Stebbing, J., Coombes, R.C., Shaw, J.A., Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One, 8, 2013, e77963.
14. 14 Mauger, F., Dulary, C., Daviaud, C., Deleuze, J.F., Tost, J., Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma. Anal Bioanal Chem 407 (2015), 6873–6878.
15. 15 Thakur, B.K., Zhang, H., Becker, A., Matei, I., Huang, Y., Costa-Silva, B., Zheng, Y., Hoshino, A., Brazier, H., Xiang, J., Williams, C., Rodriguez-Barrueco, R., Silva, J.M., Zhang, W., Hearn, S., Elemento, O., Paknejad, N., Manova-Todorova, K., Welte, K., Bromberg, J., Peinado, H., Lyden, D., Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24 (2014), 766–769.
16. 16 Guo, K., Zhang, Z., Han, L., Han, J., Wang, J., Zhou, Y., Liu, H., Tong, L., Li, X., Yan, X., Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer. Onco Targets Ther 8 (2015), 3289–3296.
17. 17 Mouliere, F., El Messaoudi, S., Gongora, C., Guedj, A.S., Robert, B., Del Rio, M., Molina, F., Lamy, P.J., Lopez-Crapez, E., Mathonnet, M., Ychou, M., Pezet, D., Thierry, A.R., Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load. Transl Oncol 6 (2013), 319–328.
18. 18 Bettegowda, C., Sausen, M., Leary, R.J., Kinde, I., Wang, Y., Agrawal, N., et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med, 6, 2014, 224ra224.
19. 19 Crowley, E., Di Nicolantonio, F., Loupakis, F., Bardelli, A., Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 10 (2013), 472–484.
20. 20 Seki, Y., Fujiwara, Y., Kohno, T., Takai, E., Sunami, K., Goto, Y., Horinouchi, H., Kanda, S., Nokihara, H., Watanabe, S., Ichikawa, H., Yamamoto, N., Kuwano, K., Ohe, Y., Picoliter-droplet digital polymerase chain reaction-based analysis of cell-free plasma DNA to assess EGFR mutations in lung adenocarcinoma that confer resistance to tyrosine-kinase inhibitors. Oncologist 21 (2016), 156–164.
21. 21 Janku, F., Angenendt, P., Tsimberidou, A.M., Fu, S., Naing, A., Falchook, G.S., Hong, D.S., Holley, V.R., Cabrilo, G., Wheler, J.J., Piha-Paul, S.A., Zinner, R.G., Bedikian, A.Y., Overman, M.J., Kee, B.K., Kim, K.B., Kopetz, E.S., Luthra, R., Diehl, F., Meric-Bernstam, F., Kurzrock, R., Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget 6 (2015), 12809–12821.
22. 22 Jamal-Hanjani, M., Wilson, G.A., Horswell, S., Mitter, R., Sakarya, O., Constantin, T., Salari, R., Kirkizlar, E., Sigurjonsson, S., Pelham, R., Kareht, S., Zimmermann, B., Swanton, C., Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. Ann Oncol 27 (2016), 862–867.